Therapy Development in the Era of Team Science and Big Data: What Will the Future Bring to the Patient with Epilepsy?
The University of Utah Anticonvulsant Drug Development Program is proud to be the host for the 2015 ADD Program Symposium, with the overarching theme of “Therapy Development in the Era of Team Science & Big Data: What Will the Future Bring to the Patient with Epilepsy?” The goal of the symposium is to explore how innovative breakthroughs in basic science can be leveraged by public, federal, and private partnerships to rapidly develop new treatments for the patient with epilepsy. Over the last 40 years, The University of Utah ADD Program has been federally-funded to provide the public and private epilepsy research community with a means to advance new treatments for epilepsy to the clinic.
Date: May 17–20, 2015
Location: Park City Marriott Hotel, Park City, Utah
The aim of this meeting is to bring together basic and clinical researchers from around the world who have a special interest in team science approaches to translational innovation for epilepsy. This symposium will provide an opportunity for exchanging ideas in order to advance novel approaches and theories for the treatment of epilepsy. This meeting, by combining the expertise of clinicians and researchers who are passionate about translational research and development, will educate and update participants on the most recent advances in our understanding of the pathophysiology of epilepsy. The ultimate goal and objective of this symposium is to facilitate new knowledge, new collaborations, and new insight into state of the art therapy development for the patient who is either at risk for developing epilepsy or who has pharmacoresistant epilepsy.
The meeting will be open to the public and we encourage submission of abstracts for poster presentations from junior investigators. Importantly, sessions are being designed that will include oral presentations from junior investigators who submit an outstanding abstract relevant to the program session. More details about this symposium will be forthcoming. In the meantime, we ask that you HOLD THE DATES and plan to attend what promises to be an exciting and state-of-the-art symposium on how scientific discoveries today will inform therapy development tomorrow.